vs
InfuSystem Holdings, Inc（INFU）与万物新生（RERE）财务数据对比。点击上方公司名可切换其他公司
万物新生的季度营收约是InfuSystem Holdings, Inc的1.2倍（$43.2M vs $36.2M）
InfuSystem Holdings, Inc.是总部位于美国的医疗服务及设备供应商，主打输液治疗解决方案，提供可编程输液泵、配套一次性医用耗材及专业临床支持服务，服务覆盖北美地区的肿瘤诊所、家庭医疗服务商及急症护理机构。
万物新生集团（ATRenew Inc.）是中国领先的二手消费电子产品交易与服务平台运营商，核心业务覆盖数码产品回收、质检、翻新及售卖，运营有爱回收等知名品牌，服务覆盖个人消费者及企业客户，市场遍及国内及部分东南亚地区。
INFU vs RERE — 直观对比
营收规模更大
RERE
是对方的1.2倍
$36.2M
损益表 — Q4 FY2025 vs Q1 FY2023
| 指标 | | |
|---|---|---|
| 营收 | $36.2M | $43.2M |
| 净利润 | — | $7.3M |
| 毛利率 | 56.4% | — |
| 营业利润率 | 10.3% | — |
| 净利率 | — | 16.9% |
| 营收同比 | 7.0% | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INFURERE
| Q4 25 | $36.2M | — | ||
| Q3 25 | $36.5M | — | ||
| Q2 25 | $36.0M | — | ||
| Q1 25 | $34.7M | — | ||
| Q4 24 | $33.8M | — | ||
| Q3 24 | $35.3M | — | ||
| Q2 24 | $33.7M | — | ||
| Q1 24 | $32.0M | — |
净利润INFURERE
| Q4 25 | — | — | ||
| Q3 25 | $2.3M | — | ||
| Q2 25 | $2.6M | — | ||
| Q1 25 | $-267.0K | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $1.8M | — | ||
| Q2 24 | $717.0K | — | ||
| Q1 24 | $-1.1M | — |
毛利率INFURERE
| Q4 25 | 56.4% | — | ||
| Q3 25 | 57.1% | — | ||
| Q2 25 | 55.2% | — | ||
| Q1 25 | 55.2% | — | ||
| Q4 24 | 53.8% | — | ||
| Q3 24 | 53.9% | — | ||
| Q2 24 | 49.5% | — | ||
| Q1 24 | 51.5% | — |
营业利润率INFURERE
| Q4 25 | 10.3% | — | ||
| Q3 25 | 10.4% | — | ||
| Q2 25 | 10.5% | — | ||
| Q1 25 | 1.8% | — | ||
| Q4 24 | 7.7% | — | ||
| Q3 24 | 9.2% | — | ||
| Q2 24 | 5.5% | — | ||
| Q1 24 | -2.6% | — |
净利率INFURERE
| Q4 25 | — | — | ||
| Q3 25 | 6.2% | — | ||
| Q2 25 | 7.2% | — | ||
| Q1 25 | -0.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.1% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | -3.5% | — |
每股收益（稀释后）INFURERE
| Q4 25 | $0.09 | — | ||
| Q3 25 | $0.11 | — | ||
| Q2 25 | $0.12 | — | ||
| Q1 25 | $-0.01 | — | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.08 | — | ||
| Q2 24 | $0.03 | — | ||
| Q1 24 | $-0.05 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.2M | $228.0M |
| 总债务越低越好 | $19.6M | — |
| 股东权益账面价值 | $57.3M | $557.1M |
| 总资产 | $100.6M | $722.9M |
| 负债/权益比越低杠杆越低 | 0.34× | — |
8季度趋势，按日历期对齐
现金及短期投资INFURERE
| Q4 25 | $3.2M | — | ||
| Q3 25 | $955.0K | — | ||
| Q2 25 | $720.0K | — | ||
| Q1 25 | $1.5M | — | ||
| Q4 24 | $527.0K | — | ||
| Q3 24 | $380.0K | — | ||
| Q2 24 | $146.0K | — | ||
| Q1 24 | $822.0K | — |
总债务INFURERE
| Q4 25 | $19.6M | — | ||
| Q3 25 | $20.9M | — | ||
| Q2 25 | $26.3M | — | ||
| Q1 25 | $28.7M | — | ||
| Q4 24 | $23.9M | — | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $34.2M | — | ||
| Q1 24 | $29.9M | — |
股东权益INFURERE
| Q4 25 | $57.3M | — | ||
| Q3 25 | $55.5M | — | ||
| Q2 25 | $54.5M | — | ||
| Q1 25 | $55.1M | — | ||
| Q4 24 | $57.5M | — | ||
| Q3 24 | $55.5M | — | ||
| Q2 24 | $53.5M | — | ||
| Q1 24 | $52.3M | — |
总资产INFURERE
| Q4 25 | $100.6M | — | ||
| Q3 25 | $98.9M | — | ||
| Q2 25 | $100.8M | — | ||
| Q1 25 | $104.3M | — | ||
| Q4 24 | $103.6M | — | ||
| Q3 24 | $105.3M | — | ||
| Q2 24 | $108.5M | — | ||
| Q1 24 | $104.8M | — |
负债/权益比INFURERE
| Q4 25 | 0.34× | — | ||
| Q3 25 | 0.38× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | 0.52× | — | ||
| Q4 24 | 0.41× | — | ||
| Q3 24 | 0.50× | — | ||
| Q2 24 | 0.64× | — | ||
| Q1 24 | 0.57× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $7.1M | — |
| 自由现金流经营现金流 - 资本支出 | $7.0M | — |
| 自由现金流率自由现金流/营收 | 19.3% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $23.8M | — |
8季度趋势，按日历期对齐
经营现金流INFURERE
| Q4 25 | $7.1M | — | ||
| Q3 25 | $8.5M | — | ||
| Q2 25 | $7.0M | — | ||
| Q1 25 | $1.8M | — | ||
| Q4 24 | $7.9M | — | ||
| Q3 24 | $9.8M | — | ||
| Q2 24 | $2.3M | — | ||
| Q1 24 | $377.0K | — |
自由现金流INFURERE
| Q4 25 | $7.0M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $6.8M | — | ||
| Q1 25 | $1.6M | — | ||
| Q4 24 | $7.4M | — | ||
| Q3 24 | $9.8M | — | ||
| Q2 24 | $2.0M | — | ||
| Q1 24 | $195.0K | — |
自由现金流率INFURERE
| Q4 25 | 19.3% | — | ||
| Q3 25 | 23.1% | — | ||
| Q2 25 | 18.9% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 21.9% | — | ||
| Q3 24 | 27.7% | — | ||
| Q2 24 | 5.9% | — | ||
| Q1 24 | 0.6% | — |
资本支出强度INFURERE
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 0.6% | — |
现金转化率INFURERE
| Q4 25 | — | — | ||
| Q3 25 | 3.76× | — | ||
| Q2 25 | 2.70× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.45× | — | ||
| Q2 24 | 3.22× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INFU
| Patient Services | $20.0M | 55% |
| Device Solutions | $14.4M | 40% |
| Other | $1.9M | 5% |
RERE
暂无分部数据
